Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO of MustGrow Biologics (CSE: MGRO). Colin sits down with our host Cassandra Leah to discuss food security, the food chain, the use of synthetic chemicals within farming, and the natural bio-solutions that MustGrow is bringing to market.

MustGrow Biologics is an agriculture bio-tech firm that is working to develop natural biological solutions to replace synthetic chemicals used within farming. The firm is currently focused on developing several mustard-derived biopesticides to ultimately replace these synthetic chemicals. Currently, the firm is largely focused on diseases such as Panama Disease, clubroot, Fusarium, and more that don’t currently have sufficient solutions in the marketplace.

View the full interview below.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Tracking Ahead Of Guidance Following Q1 Production Results

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Related News

MustGrow Achieves 100% Economical Control Of Panama Disease, Moves To Field Trials

MustGrow Biologics (CSE: MGRO) has seen further validation of its proprietary mustard derived biopesticide following...

Tuesday, February 9, 2021, 08:03:45 AM

MustGrow Biologics Isolates Third Molecule From Mustard Plant

MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different...

Wednesday, March 3, 2021, 08:46:13 AM

MustGrow Biologics Closes Financing At Final Figure Of $7.1 Million

MustGrow Biologics (CSE: MGRO) this morning closed off its previously announced private placement financing. The...

Thursday, October 7, 2021, 07:52:23 AM

MustGrow Biologics More Than Triples Financing To $6.9 Million Due To Demand

Demand within the natural biopesticide space from investors appears to be extremely strong. MustGrow Biologics...

Wednesday, September 29, 2021, 08:21:37 AM

MustGrow Sees Executive From Impossible Foods Appointed To Board

MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed...

Monday, December 14, 2020, 07:25:26 AM